AbCellera Biologics Inc. (ABCL) News
Filter ABCL News Items
ABCL News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ABCL News Highlights
- For ABCL, its 30 day story count is now at 4.
- Over the past 14 days, the trend for ABCL's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- DRUG and WAVE are the most mentioned tickers in articles about ABCL.
Latest ABCL News From Around the Web
Below are the latest news stories about ABCELLERA BIOLOGICS INC that investors may wish to consider to help them evaluate ABCL as an investment opportunity.
AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024VANCOUVER, British Columbia, December 20, 2023--AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 2:15 p.m. Pacific Time (5:15 p.m. Eastern Time). |
AI Meets Biotech: 3 Top Stocks Transforming Medical ScienceThe AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology. |
16 Best Penny Stocks To Buy For 2024In this article, we will take a detailed look at the 16 Best Penny Stocks To Buy For 2024. For a quick overview of such stocks, read our article 5 Best Penny Stocks To Buy For 2024. The stock market’s optimism wave recently saw a break after latest data showed that the US labor market remains resilient despite […] |
Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In NovemberThe AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions. |
AbCellera Biologics Insiders Added US$2.47m Of Stock To Their HoldingsOver the last year, a good number of insiders have significantly increased their holdings in AbCellera Biologics Inc... |
AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023VANCOUVER, British Columbia, November 16, 2023--AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023 |
AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023VANCOUVER, British Columbia, November 03, 2023--AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023 |
AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2023 Earnings Call TranscriptAbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2023 Earnings Call Transcript November 2, 2023 AbCellera Biologics Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.14. Operator: Good afternoon, and welcome to AbCellera’s Third Quarter 2023 Business Update Conference Call. My name is Kate, and I will facilitate the audio portion of today’s interactive broadcast. [Operator […] |
Q3 2023 Abcellera Biologics Inc Earnings CallQ3 2023 Abcellera Biologics Inc Earnings Call |
Prelude Therapeutics Inc (PRLD) Reports Q3 Financial Results and Strategic Pipeline ProgressCompany prioritizes SMARCA2 degrader and CDK9 inhibitor programs, reports cash runway into 2026 |